Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors

Pharmacological Reports

Volumn 58, Issue 3, 2006, Pages 381-392

  Gabryel, Bozena ^a   Małecki, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Apoptosis; Astrocytes; Cystine; Ebselen; Glutathione; Ischemia; Methionine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BUTHIONINE SULFOXIMINE; CYSTINE; EBSELEN; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; HOE 33342; METHIONINE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DAMAGE; CELL DEGENERATION; CELL FUNCTION; CELL MEMBRANE POTENTIAL; CELL PROTECTION; CONTROLLED STUDY; CYTOPLASM; EXPERIMENTAL DESIGN; GLUTATHIONE METABOLISM; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR SPACE; ISCHEMIA; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; RAT; SIMULATION;

EID: 33746332694     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Anderson ME, Luo JL: Glutathione therapy: from prodrugs to genes. Semin Liver Dis, 1998, 18, 415-424.
2. Aschner M: Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels. Neurotoxicology, 2000, 21, 1101-1108.
3. Awata S, Nakayama K, Suzuki I, Sugahara K, Kodama H: Changes in cystathionine gamma-lyase in various regions of rat brain during development. Biochem Mol Biol Int, 1995, 35,1331-1338.
4. Barker JE, Heales SJ, Cassidy A, Bolanos JP, Land JM, Clark JB: Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res, 1996, 716, 118-122.
5. Chao CC, Gekker G, Hu S, Sheng WS, Portoghese PS, Peterson PK: Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol, 1995, 50, 715-722.
6. Choi DW, Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci, 1990, 13, 171-182.
7. Cooper AJL, Kristal BS: Multiple roles of glutathione in the central nervous system. Biol Chem, 1997, 378, 793-802.
8. Dringen R, Kranich O, Hamprecht B: The gammaglutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture. Neurochem Res, 1997, 22, 727-733.
9. Dringen R, Hamprecht B, Drukarch B: Anethole dithiolethione, a putative neuroprotectant, increases intracellular and extracellular glutathione levels during starvation of cultured astroglial cells. Naunyn Schmiedebergs Arch Pharmacol, 1998, 358, 616-622.
10. Dringen R, Pfeiffer B, Hamprecht B: Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci, 1999,19, 562-569.
11. Gabryel B, Chalimoniuk M, Malecki A, Strosznajder JB: Effect of aniracetam on phospatidylinositol transfer protein alpha in cytosolic and plasma membranes fractions of astrocytes subjected to simulated ischemia in vitro. Pharmacol Rep, 2005, 57, 664-669.
12. Gabryel B, Pudelko A, Malecki A: Erk1/2 and Akt kinases are involved in the protective effect of aniracetam in astrocytes subjected to simulated ischemia in vitro. Eur J Pharmacol, 2004, 494, 111-120.
13. Gabryel B, Toborek T, Malecki A: Immunophilin ligands attenuate damage in rat astrocyte cultures simultaneously depleted of glutathione and exposed to simulated ischemia in vitro. Comparison with N-acetylcysteine. Neurotoxicology, 2005, 26, 373-384.
14. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, Civitareale P, Ciriolo MR: Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J, 1998, 12, 479-486.
15. Griffith OW: Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologous, potent inhibitors of glutathione synthesis. J Biol Chem, 1982, 257, 13704-13712.
16. Griffith OW, Meister A: Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci USA, 1985, 82, 4668-4672.
17. Griffith OW, Meister A: Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 1979, 245, 7558-7560.
18. Green DR, Reed JC: Mitochondria and apoptosis. Science, 1998, 281, 1309-1312.
19. Guo N, McIntosh C, Shaw C: Glutathione: new candidate neuropeptide in the central nervous system. Neuroscience, 1992, 51, 835-842.
20. Hall ED: The role of oxygen radicals in traumatic injury: clinical implications. J Emerg Med, 1993, 11, 31-36.
21. Halliwell B: Reactive oxygen species and central nervous system. J Neurochem, 1992, 59, 1609 -1623.
22. Herin GA, Du S, Aizenman E: The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site. J Neurochem, 2001, 78, 1307-1314.
23. Hertz L, Juurlink BHJ, Szuchet S: Cell cultures. In: Handbook of Neurochemistry. Ed. Lajtha A, Plenum Press, New York, 1985, Vol. 8, 603-661.
24. Jain A, J, Stole E, Auld PA, Meister A: Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA, 1991, 88, 1913-1191.
25. James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S: Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology, 2005, 26, 1-8.
26. Juurlink BH, Schultke E, Hertz L: Glutathione release and catabolism during energy substrate restriction in astrocytes. Brain Res, 1996, 710, 229-233.
27. Kim BT, Rao VL, Sailor KA, Bowen KK, Dempsey RJ: Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats. J Neurosurg, 2001, 95, 674-679.
28. Kowaltowski AJ, Nett LES, Vercesi AE: The thiolspecific antioxidant enzyme prevents mitochondrial permeability transition. Evidence for the participation of reactive oxygen species in this mechanism. J Biol Chem, 1998, 273, 12766-12769.
29. Kranich O, Dringen R, Sandberg M, Hamprecht B: Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia, 1998, 22, 11-18.
30. Lapchak PA, Zivin JA: Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator. Stroke, 2003, 34, 2013-2018.
31. Maiorino M, Roveri A, Ursini F: Antioxidant effect of Ebselen (PZ 51): peroxidase mimetic activity on phospholipid and cholesterol hydroperoxides vs free radical scavenger activity. Arch Biochem Biophys, 1992, 295, 404-409.
32. Makarov PR, Wiswedel I, Augustin W, Schild L: Hypoxia/ reoxygenation-induced damage to mitochondrial activity is determined by glutathione threshold in astroglia-rich cell cultures. Brain Res, 2002, 933, 91-97.
33. Małecki A, Garrido R, Mattson MP, Hennig B, Toborek M: 4-Hydroxynonenal induces oxidative stress and death of cultured spinal cord neurons. J Neurochem, 2000, 74, 2278-2287.
34. Martensson J, Jain A, Stole E, Frayer W, Auld PA, Meister A: Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci USA, 1991, 88, 9360-9364.
35. Mattson MP, Barger SW, Begley JG, Mark RJ: Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol, 1995, 46, 187-216.
36. Meister A: Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther, 1991, 51, 155-194.
37. Meister A, Anderson ME: Glutathione. Annu Rev Biochem, 1983, 52, 711-760.
38. Mizui T, Kinouchi H, Chan PH: Depletion of brain glutathione by buthionine sulfoximine enhances cerebral ischemic injury in rats. Am J Physiol, 1992, 262, 313-317.
39. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65, 55-63.
40. Muller A, Cadenas E, Graf P, Sies H: A novel biologically active seleno-organic compound-I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol, 1984, 33, 3235-3239.
41. Mytilineou C, Leonardi EK, Radcliffe P, Heinonen EH, Han SK, Werner P, Cohen G, Olanow CW: Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J Pharmacol Exp Ther, 1998, 284, 700-706.
42. Namura S, Nagata I, Takami S, Masayasu H, Kikuchi H: Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke, 2001, 32, 1906-1911.
43. O'Connor E, Devesa A, Garcia C, Puertes IR, Pellin A, Vina JR: Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of L-cystine and ascorbate. Brain Res, 1995, 22, 157-163.
44. Ogawa A, Yoshimoto T, Kikuchi H, Sano K, Saito I, Yamaguchi T, Yasuhara H: Ebselen in acute middle cerebral artery occlusion: a placebo-controlled, double-blind clinical trial. Cerebrovasc Dis, 1999, 9, 112-118.
45. Ramakrishnan N, Kalinich JF, McClain DE: Ebselen inhibition of apoptosis by reduction of peroxides. Biochem Pharmacol, 1996, 51, 1443-1451.
46. Reers M, Smith TW, Chen LB: J-aggregate formation of a carbocyanine fluorescent indicator of membrane potential. Biochemistry, 1991, 30, 4480-4486.
47. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H et al.: Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery, 1998, 42, 269-277.
48. Sagara J, Miura K, Bannai S: Cystine uptake and glutahione level in fetal brain cells in primary culture and suspension. J Neurochem, 1993, 61, 1667-1671.
49. Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee KY, Maruyama I: Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. J Neurochem, 2003, 87, 1345-1353.
50. Schewe T: Molecular actions of ebselen - an antiinflammatory antioxidant. Gen Pharmacol, 1995, 26, 1153-1169.
51. Shearman MS, Hawtin SR, Tailor VJ: The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J Neurochem, 1995, 65, 218-227.
52. Shrieve DC, Bump EA, Rice GC: Heterogenity of cellular glutathione among cells derived from a murine fibrosarcoma or a human renal cell carcinoma detected by flow cytometric analysis. J Biol Chem, 1988, 263, 14107-14114.
53. Sies H, Masumoto H: Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol, 1997, 38, 229-246.
54. Simmons ML, Murphy S: Induction of nitric oxide synthase in glial cells. J Neurochem, 1992, 59, 897-905.
55. Spallholz JE: Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci, 1997, 10, 260-270.
56. Swanson RA, Ying W, Kauppinen TM: Astrocyte influences on ischemic neuronal death. Curr Mol Med, 2004, 4, 193-205.
57. Takuma K, Baba A, Matsuda T: Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol, 2004, 72, 111-127.
58. Tiegs G, Kusters S, Kunstle G, Hentze H, Kiemer AK, Wendel A: Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. J Pharmacol Exp Ther, 1998, 287, 1098-1104.
59. Vercesi AE, Kowaltowski AJ, Meinicke AR, Castilho RF: The role of reactive oxygen species in mitochondrial permeability transition. Biosci Rep, 1997, 17, 43-52.
60. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H: Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke, 1998, 29, 12-17.
61. Yoshizumi M Kogame T, Suzaki Y, Fujita Y, Kyaw M, Kirima K, Ishizawa K et al.: Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells. Br J Pharmacol, 2002, 136, 1023-1032.
62. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA et al.: Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med, 1995, 182, 367-377.